Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience (Q64377232)
Jump to navigation
Jump to search
scientific article published on 19 February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience |
scientific article published on 19 February 2007 |
Statements
Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience (English)
Sanjay Rajagopalan
Jeffrey Olin
Steven Deitcher
Ann Pieczek
John Laird
P Michael Grossman
Corey K Goldman
Kevin McEllin
Ralph Kelly
Nicolas Chronos
19 February 2007